Form SC 13G - Statement of Beneficial Ownership by Certain Investors
November 06 2024 - 9:02PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b), (c),
AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No. )1
T2 Biosystems, Inc.
|
(Name of Issuer) |
Common Stock, par value $0.001 per share
|
(Title of Class of Securities) |
October 30, 2024
|
(Date of Event Which Requires Filing of this
Statement) |
Check the appropriate box
to designate the rule pursuant to which this Schedule is filed:
1
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided
in a prior cover page.
The information required
on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities
Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject
to all other provisions of the Act (however, see the Notes).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
NAME OF REPORTING PERSON |
|
|
|
|
|
|
|
|
|
|
JACOB SAFIER |
|
|
2 |
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
(a) ☐ |
|
|
|
|
(b) ☐ |
|
|
|
|
|
|
|
3 |
|
SEC USE ONLY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 |
|
CITIZENSHIP OR PLACE OF ORGANIZATION |
|
|
|
|
|
|
|
|
|
|
UNITED STATES |
|
NUMBER OF |
|
5 |
|
SOLE VOTING POWER |
|
SHARES |
|
|
|
|
|
BENEFICIALLY |
|
|
|
|
1,000,000 |
|
OWNED BY |
|
6 |
|
SHARED VOTING POWER |
|
EACH |
|
|
|
|
|
REPORTING |
|
|
|
|
-0- |
|
PERSON WITH |
|
7 |
|
SOLE DISPOSITIVE POWER |
|
|
|
|
|
|
|
|
|
|
|
|
1,000,000 |
|
|
|
8 |
|
SHARED DISPOSITIVE POWER |
|
|
|
|
|
|
|
|
|
|
|
|
-0- |
|
|
9 |
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON |
|
|
|
|
|
|
|
|
|
|
1,000,000 |
|
|
10 |
|
CHECK BOX IF THE
AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |
☐ |
|
|
|
|
|
|
|
|
|
|
|
|
11 |
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) |
|
|
|
|
|
|
|
|
|
|
5.7% |
|
|
12 |
|
TYPE OF REPORTING PERSON |
|
|
|
|
|
|
|
|
|
|
IN |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
NAME OF REPORTING PERSON |
|
|
|
|
|
|
|
|
|
|
JSAF HOLDINGS, LLC |
|
|
2 |
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
(a) ☐ |
|
|
|
|
(b) ☐ |
|
|
|
|
|
|
|
3 |
|
SEC USE ONLY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 |
|
CITIZENSHIP OR PLACE OF ORGANIZATION |
|
|
|
|
|
|
|
|
|
|
DELAWARE |
|
NUMBER OF |
|
5 |
|
SOLE VOTING POWER |
|
SHARES |
|
|
|
|
|
BENEFICIALLY |
|
|
|
|
1,000,000 |
|
OWNED BY |
|
6 |
|
SHARED VOTING POWER |
|
EACH |
|
|
|
|
|
REPORTING |
|
|
|
|
-0- |
|
PERSON WITH |
|
7 |
|
SOLE DISPOSITIVE POWER |
|
|
|
|
|
|
|
|
|
|
|
|
1,000,000 |
|
|
|
8 |
|
SHARED DISPOSITIVE POWER |
|
|
|
|
|
|
|
|
|
|
|
|
-0- |
|
|
9 |
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON |
|
|
|
|
|
|
|
|
|
|
1,000,000 |
|
|
10 |
|
CHECK BOX IF THE
AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |
☐ |
|
|
|
|
|
|
|
|
|
|
|
|
11 |
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) |
|
|
|
|
|
|
|
|
|
|
5.7% |
|
|
12 |
|
TYPE OF REPORTING PERSON |
|
|
|
|
|
|
|
|
|
|
OO |
|
| Item 1(a). | Name of Issuer: |
T2 Biosystems, Inc. (the “Issuer”).
| Item 1(b). | Address of Issuer’s Principal Executive Offices: |
101 Hartwell Ave.
Lexington, MA 02421
| Item 2(a). | Name of Person Filing: |
| Item 2(b). | Address of Principal Business Office or, if None, Residence: |
JSAF Holdings, LLC (“JSAF”)
c/o The Wolfson Group
One State Street Plaza, 29th Floor
New York, NY 10004
Citizenship: United States
Jacob Safier
c/o The Wolfson Group
One State Street Plaza, 29th Floor
New York, NY 10004
Citizenship: United States
Each of the foregoing is referred to as
a “Reporting Person” and collectively as the “Reporting Persons.”
| Item 2(d). | Title of Class of Securities: |
Common Stock, par value $0.001 per share (the “Shares”).
89853L302
| Item 3. | If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: |
|
|
/x/ |
Not applicable. |
|
|
|
|
|
(a) |
/ / |
Broker or dealer registered under Section 15 of the Exchange Act. |
|
|
|
|
|
(b) |
/ / |
Bank as defined in Section 3(a)(6) of the Exchange Act. |
|
|
|
|
|
(c) |
/ / |
Insurance company as defined in Section 3(a)(19) of the Exchange Act. |
|
|
|
|
|
(d) |
/ / |
Investment company registered under Section 8 of the Investment Company Act. |
|
|
|
|
|
(e) |
/ / |
An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E). |
|
|
|
|
|
(f) |
/ / |
An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F). |
|
|
|
|
|
(g) |
/ / |
A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G). |
|
|
|
|
|
(h) |
/ / |
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act. |
|
|
|
|
|
(i) |
/ / |
A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act. |
|
|
|
|
|
(j) |
/ / |
Non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J). |
|
|
|
|
|
(k) |
/ / |
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____ |
| (a) | Amount beneficially owned: |
As of the date hereof:
JSAF beneficially owns 1,000,000 Shares.
Jacob Safier, as the portfolio manager
of the T2 Biosystems, Inc. investment by JSAF, may be deemed to beneficially own the Shares owned by JSAF and, therefore, may be deemed
to beneficially own 1,000,000 Shares.
As of the date hereof, JSAF beneficially owned
and Jacob Safier may be deemed to beneficially own 5.7% (based upon 17,479,954 Shares outstanding, which is the number of Shares reported
as outstanding in the Issuer’s Quarterly Statement on Form 10-Q filed with the Securities and Exchange Commission on August 8, 2024).
| (c) | Number of shares as to which such person has: |
| (i) | Sole power to vote or to direct the vote: |
1,000,000 Shares.
| (ii) | Shared power to vote or to direct the vote: |
0 Shares.
| (iii) | Sole power to dispose or to direct the disposition of: |
1,000,000 Shares
| (iv) | Shared power to dispose or to direct the disposition of: |
0 Shares.
| Item 5. | Ownership of Five Percent or Less of a Class. |
Not Applicable.
| Item 6. | Ownership of More than Five Percent on Behalf of Another Person. |
Not Applicable.
| Item 7. | Identification and Classification of the Subsidiary That Acquired the Security Being Reported on by the Parent Holding Company
or Control Person. |
Not Applicable.
| Item 8. | Identification and Classification of Members of the Group. |
Not Applicable.
| Item 9. | Notice of Dissolution of Group. |
Not Applicable.
By signing below each of the undersigned
certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose
of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in
connection with or as a participant in any transaction having that purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of his or her
knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.
Dated: November 6, 2024
|
JSAF Holdings, LLC |
|
|
|
By: |
/s/ Jacob Safier |
|
|
Name: |
Jacob Safier |
|
|
Title: |
Manager |
|
/s/ Jacob Safier |
|
Jacob Safier |
Exhibit 99.1
Joint Filing Agreement
The undersigned hereby agree
that the Statement on Schedule 13G dated November 6, 2024 with respect to the Common Stock, par value $0.001 per share, of T2 Biosystems,
Inc., a Delaware corporation, and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf
of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of
1934, as amended.
Dated: November 6, 2024
|
JSAF Holdings, LLC |
|
|
|
By: |
/s/ Jacob Safier |
|
|
Name: |
Jacob Safier |
|
|
Title: |
Manager |
|
/s/ Jacob Safier |
|
Jacob Safier |
T2 Biosystems (NASDAQ:TTOO)
Historical Stock Chart
From Nov 2024 to Dec 2024
T2 Biosystems (NASDAQ:TTOO)
Historical Stock Chart
From Dec 2023 to Dec 2024